Publications by authors named "Shellie Keast"

Claim this Profile
A
A primer on brand-name prescription drug contracting.
James T Kenney, Shellie Keast

J Manag Care Spec Pharm· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Readmissions, costs, and duration to subsequent outpatient visit after hospital discharge among Medicaid beneficiaries utilizing oral versus long-acting injectable antipsychotics in bipolar disorder or schizophrenia.
Laura M Tidmore, Shellie L Keast, Heidi C Waters, Kristin L Pareja, Terry Cothran

Curr Med Res Opin· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical opportunities for pharmacists to optimize psychotropic medication use among foster youth.
Tammy L Lambert, Laura M Tidmore, Madison Holbrook, Deborah Shropshire, Nancy Nesser, Shellie Keast

J Am Pharm Assoc (2003)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prescription Opioid Dispensing Patterns Prior to Heroin Overdose in a State Medicaid Program: a Case-Control Study.
Daniel M Hartung, Kirbee A Johnston, Sara Hallvik, Gillian Leichtling, Jonah Geddes, Shellie Keast

J Gen Intern Med· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pharmacist's role in shaping the future of value-based payment models in state Medicaid programs.
Terry Cothran, Bethany Holderread, Melissa Abbott, Nancy Nesser, Shellie Keast

J Am Pharm Assoc (2003)· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Chronic Multiclass Psychotropic Polypharmacy and Psychotherapy in Foster Care Youth in a State Medicaid Population.
Shellie L Keast, Laura M Tidmore, Deborah Shropshire, Nancy Nesser, Tammy L Lambert

J Manag Care Spec Pharm· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C Direct-Acting Antiviral Treatment Selection, Treatment Failure, and Use of Drug-Drug Interactions in a State Medicaid Program.
Shellie L Keast, Bethany Holderread, Terry Cothran, Grant H Skrepnek

J Manag Care Spec Pharm· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of a high dosage opioid prior authorization policy on prescription opioid use, misuse, and overdose outcomes.
Daniel M Hartung, Hyunjee Kim, Sharia M Ahmed, Luke Middleton, Shellie Keast

Subst Abus· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
National estimates of case-mix, mortality, and economic outcomes among inpatient HIV/AIDS mono-infection and hepatitis C co-infection cases in the US.
Timothy Pham, R Chris Rathbun, Shellie Keast, Nancy Nesser, Kevin Farmer

J Eval Clin Pract· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacist-managed short-acting beta agonist refill service in a general pediatric clinic.
Brooke L Gildon, Barnabas John, Michelle Condren, Shellie Keast, Roxanne Maglunog

J Am Pharm Assoc (2003)· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the effect of an enhanced prior authorization and management program in a United States Medicaid program on chronic hepatitis C treatment adherence and cost.
Shellie L Keast, Bethany Holderread, Terry Cothran, Grant H Skrepnek

J Am Pharm Assoc (2003)· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Community pharmacists' beliefs regarding improvement of Star Ratings scores using the Theory of Planned Behavior.
David L George, Michael J Smith, JoLaine R Draugalis, Eleni L Tolma, Shellie L Keast

J Am Pharm Assoc (2003)· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overview of Prescription Opioid Deaths in the Oklahoma State Medicaid Population, 2012-2016.
Timothy T Pham, Grant H Skrepnek, Christopher Bond, Thomas Alfieri, Terry J Cothran, Shellie L Keast

Med Care· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained Virologic Response and Costs Associated with Direct-Acting Antivirals for Chronic Hepatitis C Infection in Oklahoma Medicaid.
Timothy T Pham, Shellie L Keast, Kevin C Farmer, David M Thompson, R Chris Rathbun

J Manag Care Spec Pharm· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of a prior authorization policy for extended-release/long-acting opioids on utilization and outcomes in a state Medicaid program.
Shellie L Keast, Hyunjee Kim, Richard A Deyo, Luke Middleton, K John McConnell

Addiction· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of think-aloud protocols to identify a decision-making process of community pharmacists aimed at improving CMS Star Ratings scores.
David L George, Michael J Smith, JoLaine R Draugalis, Eleni L Tolma, Shellie L Keast

Res Social Adm Pharm· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resource Use Evaluation of Tobramycin Formulations in a State Medicaid Program.
Shellie L Keast

J Pediatr Pharmacol Ther· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using prescription monitoring program data to characterize out-of-pocket payments for opioid prescriptions in a state Medicaid program.
Daniel M Hartung, Sharia M Ahmed, Luke Middleton, Joshua Van Otterloo, Kun Zhang, Shellie Keast

Pharmacoepidemiol Drug Saf· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incremental Effect of the Addition of Prescriber Restrictions on a State Medicaid's Pharmacy-Only Patient Review and Restriction Program.
Shellie L Keast, Timothy Pham, Ashley Teel, Nancy J Nesser

J Manag Care Spec Pharm· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does the use of atypical antipsychotics as adjunctive therapy in depression result in cost savings? Comparing healthcare costs and utilization between second-line treatment options.
Amany K Hassan, Kevin C Farmer, Nancy C Brahm, Shellie Keast, Nancy Nesser

J Ment Health· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prior authorization policies in Medicaid programs: The importance of study design and analysis on findings and outcomes from research.
Shellie L Keast, Kevin Farmer, Michael Smith, Nancy Nesser, Donald Harrison

Res Social Adm Pharm· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Abuse-Deterrent or Tamper-Resistant Opioid Formulations on Overall Health Care Expenditures in a State Medicaid Program.
Shellie L Keast, Arthur Owora, Nancy Nesser, Kevin Farmer

J Manag Care Spec Pharm· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
State Medicaid Programs Bring Managed Care Tenets to Fee for Service.
Shellie L Keast, Grant Skrepnek, Nancy Nesser

J Manag Care Spec Pharm· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies aimed at controlling misuse and abuse of opioid prescription medications in a state Medicaid program: a policymaker's perspective.
Shellie L Keast, Nancy Nesser, Kevin Farmer

Am J Drug Alcohol Abuse· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of a prior authorization policy for montelukast on clinical outcomes for asthma and allergic rhinitis among children and adolescents in a state Medicaid program.
Shellie L Keast, David Thompson, Kevin Farmer, Michael Smith, Nancy Nesser

J Manag Care Spec Pharm· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis